Actinium Pharmaceuticals Statistics
Total Valuation
ATNM has a market cap or net worth of $34.47 million. The enterprise value is -$41.70 million.
Important Dates
The next estimated earnings date is Friday, April 25, 2025, after market close.
| Earnings Date | Apr 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ATNM has 31.20 million shares outstanding. The number of shares has increased by 11.51% in one year.
| Current Share Class | 31.20M |
| Shares Outstanding | 31.20M |
| Shares Change (YoY) | +11.51% |
| Shares Change (QoQ) | +3.22% |
| Owned by Insiders (%) | 0.51% |
| Owned by Institutions (%) | 30.74% |
| Float | 31.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 435.20 |
| Forward PS | n/a |
| PB Ratio | 0.91 |
| P/TBV Ratio | 0.92 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.25, with a Debt / Equity ratio of 0.04.
| Current Ratio | 10.25 |
| Quick Ratio | 10.14 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -100.05% and return on invested capital (ROIC) is -65.57%.
| Return on Equity (ROE) | -100.05% |
| Return on Assets (ROA) | -32.85% |
| Return on Invested Capital (ROIC) | -65.57% |
| Return on Capital Employed (ROCE) | -60.46% |
| Revenue Per Employee | $1,653 |
| Profits Per Employee | -$835,000 |
| Employee Count | 49 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.23% in the last 52 weeks. The beta is 0.11, so ATNM's price volatility has been lower than the market average.
| Beta (5Y) | 0.11 |
| 52-Week Price Change | -85.23% |
| 50-Day Moving Average | 1.21 |
| 200-Day Moving Average | 3.07 |
| Relative Strength Index (RSI) | 46.79 |
| Average Volume (20 Days) | 146,515 |
Short Selling Information
The latest short interest is 2.21 million, so 7.08% of the outstanding shares have been sold short.
| Short Interest | 2.21M |
| Short Previous Month | 2.08M |
| Short % of Shares Out | 7.08% |
| Short % of Float | 7.12% |
| Short Ratio (days to cover) | 12.61 |
Income Statement
In the last 12 months, ATNM had revenue of $81,000 and -$40.92 million in losses. Loss per share was -$1.40.
| Revenue | 81,000 |
| Gross Profit | 81,000 |
| Operating Income | -44.96M |
| Pretax Income | -42.62M |
| Net Income | -40.92M |
| EBITDA | -44.73M |
| EBIT | -44.96M |
| Loss Per Share | -$1.40 |
Full Income StatementBalance Sheet
The company has $78.66 million in cash and $1.71 million in debt, giving a net cash position of $76.95 million or $2.47 per share.
| Cash & Cash Equivalents | 78.66M |
| Total Debt | 1.71M |
| Net Cash | 76.95M |
| Net Cash Per Share | $2.47 |
| Equity (Book Value) | 38.21M |
| Book Value Per Share | 1.22 |
| Working Capital | 71.77M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$34.81 million and capital expenditures -$11,000, giving a free cash flow of -$34.82 million.
| Operating Cash Flow | -34.81M |
| Capital Expenditures | -11,000 |
| Free Cash Flow | -34.82M |
| FCF Per Share | -$1.12 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -55,504.94% |
| Pretax Margin | -50,512.35% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ATNM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.51% |
| Shareholder Yield | n/a |
| Earnings Yield | -116.07% |
| FCF Yield | -98.78% |
Analyst Forecast
The average price target for ATNM is $8.75, which is 691.86% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.75 |
| Price Target Difference | 691.86% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 248.47% |
| EPS Growth Forecast (5Y) | -36.77% |
Stock ForecastsStock Splits
The last stock split was on August 11, 2020. It was a reverse split with a ratio of 0.03333333:1.
| Last Split Date | Aug 11, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.03333333:1 |
Scores
ATNM has an Altman Z-Score of -4.73 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.73 |
| Piotroski F-Score | 2 |